Manna Chemicals And Drugs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 26-12-2024
- Paid Up Capital ₹ 0.10 M
as on 26-12-2024
- Company Age 11 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 8.41%
(FY 2020)
- Profit -58.81%
(FY 2020)
- Ebitda 182.86%
(FY 2020)
- Net Worth 16.01%
(FY 2020)
- Total Assets -14.41%
(FY 2020)
About Manna Chemicals And Drugs
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Devaraj Roy and Charles serve as directors at the Company.
- CIN/LLPIN
U24240TN2013PTC091906
- Company No.
091906
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jun 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Manna Chemicals And Drugs Private Limited offer?
Manna Chemicals And Drugs Private Limited offers a wide range of products and services, including Paints, Wall Putty & Varnishes, Surface Polish, Material Testing Labs & Services, Non Destructive Testing Services, Cleaning Liquids & Wipes, Surface Cleaner, Cleaning Chemicals.
Who are the key members and board of directors at Manna Chemicals And Drugs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devaraj Roy  | Director | 28-Jun-2013 | Current |
| Charles | Director | 05-Feb-2016 | Current |
Financial Performance of Manna Chemicals And Drugs.
Manna Chemicals And Drugs Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 8.41% increase. The company also saw a substantial fall in profitability, with a 58.81% decrease in profit. The company's net worth Soared by an impressive increase of 16.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Manna Chemicals And Drugs?
In 2019, Manna Chemicals And Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Redsea Eco Solutions And Instruments Private LimitedActive 11 years 3 monthsDevaraj Roy is a mutual person
Redsea Sustainable Technologies Private LimitedActive 1 year 5 monthsDevaraj Roy is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Manna Chemicals And Drugs?
Unlock and access historical data on people associated with Manna Chemicals And Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Manna Chemicals And Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Manna Chemicals And Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
